2014 ACR/ARHP Annual Meeting Archives - Page 202 of 202

Abstract Number: 255

Pain As Predictor of Organ Involvement in Fabry Disease
Abstract Number: 258

Pain Characteristics Among Patients with Rheumatoid Arthritis in the Context of Patient-Physician Discordance in Disease Activity Assessments
Abstract Number: 1402

Parameters of Periodontitis Correlate with Anti-Citrullinated Protein Antibodies and P. Gingivalis Antibody Titers in Patients with Early or Chronic Rheumatoid Arthritis
Abstract Number: 358

Parity and Severity of ACPA-Positive/Negative Rheumatoid Arthritis. Results from the Swedish EIRA Study
Abstract Number: 1000

Pathogenic Role of CXC Chemokine receptor 3-Positive B Cells in Bone Destruction of Rheumatoid Arthritis
Abstract Number: 1255

Pathogenic Role of Tyrosyl–Transfer RNA Synthetase in Anti-Synthetase Syndrome
Abstract Number: 498

Patient Experience with Initiation of SQ and Oral MTX
Abstract Number: 2033

Patient Factors Associated with Oral Glucocorticoid Prescribing Patterns in UK Primary Care for Patients with Rheumatoid Arthritis
Abstract Number: 1380

Patient Global Impression of Change for Patient Reported Outcomes in Rheumatoid Arthritis: Impact of Comorbidities
Abstract Number: 1287

Patient Perspective of the Main Health Concerns and Needs of Living with Hand Osteoarthritis
Abstract Number: 1507

Patient Perspectives on the Introduction of Subsequent Entry Biologics in Canada
Abstract Number: 2768

Patient Reported Outcomes and Acute Phase Reactants in Polymyalgia Rheumatica in Patients Treated with Prednisone Versus Modified-Release Prednisone
Abstract Number: 108

Patient Reported Outcomes Following Total Knee Arthroplasty in Rheumatoid Arthritis and Osteoarthritis
Abstract Number: 106

Patient Reported Outcomes Following Upper Extremity Arthroplasties in RA -a Report from the Swedish National Register of Rheuma Surgery (RAKIR)
Abstract Number: 2967

Patient Reported Pain By the Paindetect Questionnaire Reveals Multimodal Elements to Pain Perception in Rheumatoid Arthritis
Abstract Number: 2421

Patient Treatment Goals in Rheumatoid Arthritis: Results of Focus Groups Among Rheumatologists, English and Spanish-Speaking Patients
Abstract Number: 428

Patient-Physician Discordance of Disease Activity Assessments Predicts Inadequate Treatment Response in Early Rheumatoid Arthritis
Abstract Number: 300

Patient-Reported Joint Count in Juvenile Idiopathic Arthritis: The Reliability of a Mannequin Format
Abstract Number: 2486

Patient-Reported Outcomes Following 12 Months of Therapy with Abatacept (Plus Methotrexate or as Monotherapy) or Methotrexate and up to 6 Months after Treatment Withdrawal in Patients with Early Rheumatoid Arthritis
Abstract Number: 492

Patient-Reported Outcomes from a Canadian Study of Patients Taking Methotrexate and Etanercept
Abstract Number: 289

Patient-Reported Outcomes in Children with Moderately to Severely Active Polyarticular or Polyarticular-Course Juvenile Idiopathic Arthritis Who Are Prescribed and Treated with Adalimumab
Abstract Number: 2520

Patient, Genetic and Disease Factors Influence the Response to the Disease Modifying Anti-Rheumatic Drug Leflunomide
Abstract Number: 2971

Patient’s Self-Monitoring Via Smartphone: The Compass Study Correlation Between Patient Self-Assessment of Rheumatoid Arthritis Disease Activity Via Smartphone Technology and Physicians’ Validated Scores
Abstract Number: 1881

Patients Who Fail Biologics Are More Likely to Have Concomitant Fibromyalgia
Abstract Number: 1466

Patients with Active Rheumatoid Arthritis Display an Expanded Population of GM-CSF Expressing Peripheral B Cells
Abstract Number: 579

Patients with Ankylosing Spondylitis Do Not Adapt to Their Disease: Evidence from the ‘then Test’ in Patients Treated with TNF-Inhibitors
Abstract Number: 2135

Patients with Moderate Disease Activity in the First 5 Years of Rheumatoid Arthritis Still Progress Radiographically Despite Conventional Disease Modifying Therapy
Abstract Number: 2593

Patients with Non-Radiographic Axial Spondyloarthritis and Ankylosing Spondylitis Demonstrate the Same Clinical Disease Course over Two Years: Results from the Gespic Cohort
Abstract Number: 589

Patients with Nr-Axspa Show a Statistically Higher Disease Burden in Clinical Practice Compared with Patients with Radiographic Axial Spa
Abstract Number: 1274

Patients with Osteoarthritis Do NOT Have Increased Risk of Cardiovascular Disease in Ullensaker Community in Norway
Abstract Number: 1059

Patients with RA from Wealthier Countries Perform Better on Clinical Disease Activity Measures, but Tend to Show Worse Person Reported Outcomes
Abstract Number: 2721

Patients’ Perspective of Skin Involvement in Systemic Sclerosis
Abstract Number: 2386

Patients’ Interpretations of Rheumatoid Arthritis Model Disease States in a Safety-Net Rheumatology Clinic
Abstract Number: 290

Patterns of Active Joint Involvement in JIA
Abstract Number: 2112

Patterns of Medication Use Before, During, and After Pregnancy Among Women with Systematic Lupus Erythematosus: A Population-Based Study
Abstract Number: 519

Patterns of Tocilizumab Use and Safety in Patients with Rheumatoid Arthritis: Interim Results from a Multinational Observational Study
Abstract Number: 1162

Patterns of Use of Long-Term (> 5 Years) Oral Bisphophonate Prescription Among Primary Care Providers and Rheumatologists for the Treatment of Osteopenia and Osteoporosis in a Veteran Population
Abstract Number: 125

PD Signal Detected By Ultrasonography Relates to Joint Destruction in Rheumatoid Arthritis Under Biologics Therapy in Real World
Abstract Number: 79

PECAM-1 GENE Polymorphisms and Soluble PECAM-1 LEVEL in Rheumatoid Arthritis and Systemic LUPUS Erythematosus Patients Is There a Link with Clinical Atherosclerotic Events?
Abstract Number: 1224

Pegloticase for Tophus Debulking: Comparison of Dual Energy Computerized Tomography (DECT), Musculoskeletal Ultrasound (MSK-US) and Topographic Caliper Measurement for Assessing Debulking Rate
Abstract Number: 2331

People’s Views, Beliefs and Experiences of Exercise for Chronic Hip and Knee Pain: Cochrane Review with Qualitative Synthesis
Abstract Number: 641

Peptidylarginine Deiminase Inhibition Mitigates NET Formation and Protects Against Kidney, Skin, and Vascular Disease in Lupus-Prone MRL/Lpr Mice
Abstract Number: 2046

Perceived Discrimination in Individuals with Radiographic Knee and Hip Osteoarthritis
Abstract Number: 2267

Percentage of Women Achieving Non-Osteoporotic BMD T-Scores at the Spine and Hip over 8 Years of Denosumab Treatment
Abstract Number: 6

Performance Evaluation and Clinical Associations of the Aphl ELISA Compared to Criteria Antiphospholipid Immunoassays in Lupus Patients
Abstract Number: 2041

Performance of a Two-Step Latent Tuberculosis Screening Algorithm in Patients with Rheumatoid Arthritis, Psoriatic Arthritis or Ankylosing Spondylitis Prior to Treatment with Tumor Necrosis Alpha Inhibitors: Prospective Observational Data from the Biorx.Si Registry, 2014 Update
Abstract Number: 15

Performance of an Automated Chemiluminescence Assay for Anti-Cardiolipin and Anti-Beta2glycoprotein I Antibodies Detection in a Cohort of 400 Clinically Characterized Consecutive Routine Samples
Abstract Number: 158

Performance of Joint Ultrasonography in the Diagnosis of Suspected Acute Crystal Arthritis : Results of a Prospective Study of 112 Patients
Abstract Number: 2014

Performance of Self-Reported Measures for Periodontitis in Rheumatoid Arthritis and Osteoarthritis
Abstract Number: 2719

Performance of the New ACR Criteria in Systemic Sclerosis: A Multicenter Study
Abstract Number: 2535

Performance of the Ocular Staining Score (OSS) Vs. the Van Bijsterveld Score in the Assessment of Sjögren’s Syndrome-Related Keratoconjunctivitis Sicca
Abstract Number: 731

Performance of the Old ACR and the New ACR-EULAR Systemic Sclerosis Classification Criteria in Patients with Limited Cutaneous Disease: Effect on the Ascertainment of Severe Pulmonary Arterial Hypertension
Abstract Number: 1234

Periodic Fever Syndromes in an Academic Medical Center
Abstract Number: 1426

Periodontal disease and Clinical Activity of Rheumatoid Arthritis Patients
Abstract Number: 1393

Periodontal Disease and Its Impact on Structural Joint Damage in a Rheumatoid Arthritis Peruvian Population
Abstract Number: 603

Periostin May Have a Role in Ankylosing Spondylitis and It Is Associated with Wnt Signalling Pathway Regulators
Abstract Number: 1719

Periostin May Promote Productin of Extracellular Matrix By Modulating TGF-β Signaling in Human Skin Fibroblasts
Abstract Number: 799

Peripheral Arterial Disease in Patients with Giant Cell Arteritis: A Systematic Review and Meta-Analysis
Abstract Number: 1698

Peripheral Blood Eosinophil Counts Increase in Patients with Systemic Sclerosis and Associated with Its Disease Severity
Abstract Number: 1754

Peripheral CD5⁺b-Cells in ANCA-Associated Vasculitis
Abstract Number: 1853

Persistence and Predictors of Biologic TNFi Therapy Among Biologic naïve Psoriatic Arthritis Patients in a US Registry
Abstract Number: 1569

Persistence of Biologic Therapy in Psoriatic Disease: Results from the Psoriasis Longitudinal Assessment and Registry
Abstract Number: 1594

Persistence of Low Disease Activity after Tumor Necrosis Factor Inhibitor Withdrawal in Patients with Psoriatic Arthritis
Abstract Number: 2494

Persistence on Single Disease Modifying Anti-Rheumatic Drug Therapy in US Veterans with Rheumatoid Arthritis Is Extremely Rare
Abstract Number: 2156

Persistent Arthralgia Following Chikungunya Fever
Abstract Number: 2008

Personalized Risk Education for Rheumatoid Arthritis Improves Self-Perceived Risk Accuracy and Risk Factor Knowledge in First-Degree Relatives
Abstract Number: 2771

PET-CT Imaging and Association of Ferritin Autoantibodies in Polymyalgia Rheumatica
Abstract Number: 2364

PET-CT Imaging of Joints: A Quantitative Tool for Developing Novel Anti-Inflammatory Drugs
Abstract Number: 797

PET/CT for the Diagnosis of Giant Cell Arteritis: A Prospective Study
Abstract Number: 1998

pGALS Training Increases Kenyan Pediatric Residents’ Confidence in Performing a Musculoskeletal Exam
Abstract Number: 2444

Pharmacist-Developed Letters May Enhance Success in Obtaining Insurer Approval for Off-Label Use of Biologics
Abstract Number: 1945

Pharmacodynamic Effects of the CD22-Targeted Monoclonal Antibody Epratuzumab on B Cells in Patients with Systemic Lupus Erythematosus
Abstract Number: 1504

Pharmacokinetic Equivalence of ABP 501 Relative to Adalimumab: Results from a Randomized, Single-Blind, Single-Dose, Parallel Group Study in Healthy Subjects
Abstract Number: 1478

Pharmacokinetics, Bioavailability and Safety of a Modified-Release Once-Daily Formulation of Tofacitinib in Healthy Volunteers
Abstract Number: 677

Pharmacokinetics, Safety, and Biological Activity of Intravenously or Subcutaneously Administered Tabalumab in Subjects with Rheumatoid Arthritis or Systemic Lupus Erythematosus
Abstract Number: 282

Pharmacovigilance in Juvenile Idiopathic Arthritis Patients (PHARMACHILD) Treated with Biologic Agents and/or Methotrexate. Consolidated Baseline Characteristics from Pharmachild and Other National Registries
Abstract Number: 1481

Phase 1 and Phase 2 Data Confirm That GLPG0634, a Selective JAK1 Inhibitor, Has a Low Potential for Drug-Drug Interactions
Abstract Number: 946

Phase 1 Study of Immunotherapy Using Autoantigen-Loaded Dendritic Cells in Patients with Anti-Citrullinated Peptide Antigen Positive Rheumatoid Arthritis
Abstract Number: 923

Phenotypes of Osteoarthritis-Related Knee Pain and Their Transitions over Time: The Osteoarthritis Initiative
Abstract Number: 2460

Phospho-STAT1/3 and Gene Expression Measurement in Circulating CD4⁺ T Cells As Diagnostic Tools in Early Autoantibody-Negative Rheumatoid Arthritis
Abstract Number: 2054

Physical and Mental Functioning in Patients with Established Rheumatoid Arthritis over an 11-Year Follow-up Period: The Role of Specific Comorbidities
Abstract Number: 2941

Physical Function Is Independently Associated with Mortality Among Individuals with Knee and/or Hip OA: The Johnston County Osteoarthritis Project
Abstract Number: 1373

Physical Function of Patients with RA Varies Importantly Across Countries, and These Differences Are Not Attributed to GDP: Results from Multi-National Study with 17 Countries
Abstract Number: 44

Physical Function, Hyperuricemia and Gout in Older Adults
Abstract Number: 2227

Physical Impairment in Patients with Idiopathic Inflammatory Myopathies Is Predicted By the American College of Rheumatology Functional Status Measure
Abstract Number: 68

Physical Inactivity to Activity Associated with Less Decline in Physical Function
Abstract Number: 209

Physical Performance and Obesity Measures Are Associated with Tibial Cartilage Volume and Explains the Sex Difference in Cartilage Volume
Abstract Number: 1676

Physical Therapy for Systemic Sclerosis: Systematic Review and Meta-Analysis
Abstract Number: 2367

Physician Awareness of Suboptimal Patient Adherence to MTX: Results from a Large U.S. Rheumatoid Arthritis Registry
Abstract Number: 1990

Pilot Musculoskeletal Workshop for Internal Medicine Residents
Abstract Number: 2003

Pilot Study of a Web-Based Module on Gout
Abstract Number: 2202

Pilot Study of Tocilizumab in Patients with Erdheim-Chester Disease
Abstract Number: 2236

Plant–Derived Products Are Effective for Treatment of OA Pain and Safer Than Other Active Therapies
Abstract Number: 1200

Plasma Levels of Pattern Recognition Molecules of the Lectin Pathway Are Altered in SLE Patients
Abstract Number: 2091

Plasma Microparticle Protein Features Distinctively Classify Systemic Lupus Erythematosus and Systemic Sclerosis and Their Clinical Phenotype
Abstract Number: 2745

Plasma of Patients with Active Behçet´s Disease (BD) Increases Neutrophil Extracellular Trap Formation, Oxidative Metabolism and NADPH-Oxidase Expression in Normal and BD Neutrophils, and Carries Several Neutrophil Stimulating Factors
Abstract Number: 1779

Plasmapheresis Therapy in ANCA-Associated Vasculitides: A Single-Center Retrospective Analysis of Renal Outcome and Mortality
Abstract Number: 1727

Poly(ADP-ribose) Polymerase-1 (PARP-1) Suppresses the Profibrotic Effects of Transforming Growth Factor â in Systemic Sclerosis
Abstract Number: 2958

Polygenic Analysis of Transport, Metabolism and Immune Related Genomic Compartments in Serum Urate and Gout
Abstract Number: 2742

Polymorphisms in the Slam Family of Molecules Play a Role in the Development and Function of Invariant Natural Killer T Cells in New Zealand Black Mice
Abstract Number: 2171

Polymorphisms in theÂ FCN1Â Gene Coding for M-Ficolin Are Associated with Disease Activity, Radiographic Damage and Are the Strongest Predictors of DAS28 Remission in 180 DMARD naÃ¯ve Early Rheumatoid Arthritis Patients
Abstract Number: 2770

Polymyalgia Rheumatica Relapse and “Silence” Large Vessel Vasculitis. Is There Any Association?
Abstract Number: 893

Polysymptomatic Distress Categories for Clinical and Research Use
Abstract Number: 903

Poor Adherence to Medications for Systemic Lupus Erythematosus Predicts Higher Health Care Utilization in U.S. Medicaid Beneficiaries
Abstract Number: 1355

Population Management of Rheumatoid Arthritis (RA) in Rheumatology Practices: A Quality Improvement Project
Abstract Number: 1475

Porphyromonas Gingivalis and Bone Turnover Biomarkers in Rheumatoid Arthritis
Abstract Number: 168

Positive Association Between Tomato Consumption and Serum Urate: Investigating an Anecdotal Trigger of Gout Flares
Abstract Number: 2304

Positive HLA-B27 in Juvenile Spondyloarthritis Is Associated to Early Sacroiliitis and Progression to Ankylosing Spondylitis
Abstract Number: 2613

Positive Spine MRI for Inflammation Predicts Radiographic Progression in Patients with Ankylosing Spondylitis
Abstract Number: 94

Possible Effects of Medicare-Only Insurance Coverage on the Use of Biologics in Patients with RA
Abstract Number: 2473

Post-Marketing Surveillance of Efficacy and Safety of Tacrolimus Add-on Therapy in Japanese Rheumatoid Arthritis Patients Who Failed to Show an Adequate Response to Biological Dmards : Interim Analysis
Abstract Number: 2887

Post-Menopausal Factors and the Risk of Seropositive and Seronegative Rheumatoid Arthritis Phenotypes: Results from the Nurses’ Health Study
Abstract Number: 2708

Post-Occlusive Reactive Hyperemia (PORH) Test Mirrors Vascular Changes in Systemic Sclerosis (SSc):a Laser Speckle Contrast (LASCA) Study
Abstract Number: 752

Potential Roles of Toll-like Receptor 4 in the Murine Models of Systemic Sclerosis
Abstract Number: 2214

Power Doppler Ultrasonography for Detection of Abnormal Fascial Vascularity: A Potential Early Diagnostic Tool in Fasciitis of Dermatomyositis
Abstract Number: 1350

Practice What You Preach? Suboptimal Guideline Adherence By Rheumatologists in Patients with Rheumatoid Arthritis
Abstract Number: 1279

Pre-Operative Musculoskeletal Comorbidities Limit Improvement in Functional Outcomes and Hip Pain in Total Hip Arthroplasty Patients
Abstract Number: 193

Pre-Operative Pain and Function: Profiles of Patients Selected for Total Knee Replacement Among Surgeons in the United States
Abstract Number: 2530

PRE.MARK-TNF Test Based on Iga-Specific Autoantigens Predicts Therapy Response in Rheumatoid Arthritis Patients Treated with TNFα Inhibitors
Abstract Number: 2930

Precisely Quantified Fibrosis in Labial Salivary Glands Predicts Sjögren’s Syndrome Classification in a Multiple Regression Model
Abstract Number: 742

Precision of Ultrasound Skin Thickness Measurements: Influence of Examiner and Ultrasound Transducer
Abstract Number: 1500

Preclinical and Clinical Characterization of MK-8457, a Selective Spleen Tyrosine Kinase and Zeta-Chain-Associated Protein Kinase 70 Inhibitor, in Normotensive and Hypertensive Cardiovascular Models
Abstract Number: 1495

Preclinical and Clinical Phase I Profile of MK-8457, a Selective Spleen Tyrosine Kinase and Zeta-Chain-Associated Protein Kinase 70 Inhibitor, Developed for the Treatment of Rheumatoid Arthritis
Abstract Number: 1421

Preclinical Interstitial Lung Disease in Early Rheumatoid Arthritis
Abstract Number: 944

Predict the Chance of Remission for Your RA Patient in Real Life
Abstract Number: 669

Predicted Chronic Exposure and Dose Selection for Belimumab Administered Subcutaneously to SLE Patients
Abstract Number: 303

Predicting Chronic Pain in Children with Juvenile Idiopathic Arthritis: Results from the Childhood Arthritis Prospective Study
Abstract Number: 2030

Predicting Failure of Conventional Disease Modifying Antirheumatic Drugs in Treatment Naive Early Rheumatoid Arthritis Patients: A Single Centre Inception Prognostic Factor Cohort Study
Abstract Number: 1310

Predicting Macrophage Activation Syndrome in Pediatric Systemic Lupus Erythematosus Patients at Diagnosis
Abstract Number: 1775

Predicting Relapse in Patients with Granulomatosis with Polyangiitis – the Potential Use of Monitoring in Vitro ANCA Production
Abstract Number: 1920

Predicting SLE Disease Activity in the Next Year Based on Measures of Four Gene Transcripts and Two Proteins
Abstract Number: 1542

Predicting Successful Long-Term Treatment with Tumour Necrosis Factor-Alpha Inhibitors in Patients with Psoriatic Arthritis
Abstract Number: 1740

Predicting the Evolution of Inflammatory Arthritis in ACPA-Positive Individuals: Can T-Cell Subsets Model Help?
Abstract Number: 271

Predicting Treatment Response to Etanercept in Juvenile Idiopathic Arthritis: Results from the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study (BSPAR-ETN)
Abstract Number: 728

Prediction and Impact of Attacks of Raynaud’s Phenomenon, As Judged By Patient perception
Abstract Number: 730

Prediction of Cardiac and Vascular Events in Systemic Sclerosis: Input from Endothelin-1 Type a Receptor Antibodies
Abstract Number: 722

Prediction of Improvement in Skin Fibrosis in Diffuse Cutaneous Systemic Sclerosis
Abstract Number: 1081

Prediction of Mortality Risk Related to Cerebrovascular Accidents in Patients with Systemic Lupus Erythematosus (SLE) vs Anti-Phospho-Lipid-Antibody (aPL) syndrome
Abstract Number: 2493

Prediction of Remission and Low Disease Activity in DMARD-Refractory Patients with RA Treated with Golimumab
Abstract Number: 421

Prediction of Remission By Patients and Physicians: Does the Doctor Know Best?
Abstract Number: 500

Prediction of Successful Dose Reduction or Discontinuation of Adalimumab or Etanercept Using Serum Drug Levels and Antidrug Antibody Measurement
Abstract Number: 2758

Predictive Factors for the Response to Infliximab Therapy in Patients with Behçet’s Disease
Abstract Number: 2076

Predictive Modeling of a Fibromyalgia Diagnosis: Increasing the Accuracy Using Real World Data
Abstract Number: 533

Predictive Significance of CCL21 and CXCL13 Levels in the Minor Salivary Glands of Patients with Sjögren’s Syndrome
Abstract Number: 551

Predictors Associated with Rheumatologist Referral Time in Patients with Ankylosing Spondylitis
Abstract Number: 542

Predictors for Cardiovascular Events in Patients with Psoriatic Arthritis – a Cohort Study
Abstract Number: 2496

Predictors of ACR/EULAR Boolean and SDAI Remission in Patients with Established Rheumatoid Arthritis Treated with Anti-TNF: An Analysis from the Prospective, Observational, Biological Treatment Registry Across Canada
Abstract Number: 1163

Predictors of Cholesterol and Lifestyle Discussions in Rheumatoid Arthritis Visits: Impact of Perceived RA Control and Comparison with Other Prevention Topics
Abstract Number: 1369

Predictors of Deterioration in Subjective Cognition: Results from a Rheumatoid Arthritis (RA) Observational Cohort Study
Abstract Number: 2511

Predictors of Discontinuation of Biologic DMARD Therapy Due to Remission in Patients with Rheumatoid Arthritis in a National Registry
Abstract Number: 1324

Predictors of Disease Relapse in Juvenile Localized Scleroderma
Abstract Number: 2485

Predictors of Drug-Free Remission Following Treatment with Abatacept (in Combination with Methotrexate or as Monotherapy) in Early Rheumatoid Arthritis
Abstract Number: 117

Predictors of Gout Flares in a US Managed Care Setting
Abstract Number: 2647

Predictors of Incident Seizure in Systemic Lupus Erythematosus
Abstract Number: 732

Predictors of Inpatient Mortality in Patients with Systemic Sclerosis: A Case Control Study
Abstract Number: 1392

Predictors of Long-Term Changes in Body Mass Index in Rheumatoid Arthritis
Abstract Number: 2222

Predictors of Myositis Treatments Received and Associated Treatment Responses in Myovision, a National Myositis Patient Registry
Abstract Number: 121

Predictors of Persistence of Power Doppler Ultrasound Synovitis in Rheumatoid Arthritis Patients in Clinical Remission
Abstract Number: 2754

Predictors of Quality of Life in Behçet’s Syndrome
Abstract Number: 203

Predictors of Radiographic Progression of Interphalangeal Finger Joints in Erosive Osteoarthritis: A Prospective Study
Abstract Number: 2139

Predictors of Radiologic Disease Progression during the Rheumatoid Arthritis Comparison of Active Therapies Trial
Abstract Number: 2901

Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis
Abstract Number: 2651

Predictors of Therapeutic Outcomes in Patients with Neuropsychiatric Systemic Lupus Erythematosus
Abstract Number: 2587

Predictors of Treatment Response to Tumor Necrosis Factor-Alpha Blockers in Spondyloarthritis: Systematic Review and Meta-Analysis
Abstract Number: 2648

Prednisone Is a Risk Factor for Incident Depression in Systemic Lupus Erythematosus
Abstract Number: 689

Prednisone, Disease Activity and Hypertension Independently Predict Cataracts in Systemic Lupus Erythematosus (SLE)
Abstract Number: 1143

Preferences of Biologic Treatment Characteristics Among Rheumatoid Arthritis Patients Who Are Current Biologic Therapy Users
Abstract Number: 2573

Preferences of Patients with Spondyloarthritis for the Items of the ASAS Health Index : A Best Worst Scaling
Abstract Number: 301

Pregnancies in Females with Juvenile Idiopathic Arthritis (JIA) Who Were Exposed to Biologics and/or Methotrexate – Results from a Biologic Register
Abstract Number: 821

Pregnancy Outcome in Women Treated with Adalimumab for the Treatment of Rheumatoid Arthritis: An Update
Abstract Number: 1409

Pregnancy Outcomes after Exposure to Certolizumab Pegol: Updated Results from Safety Surveillance
Abstract Number: 1840

Pregnancy Outcomes Following Exposure to Abatacept during Pregnancy
Abstract Number: 1877

Pregnancy Outcomes in SLE: Before and after
Abstract Number: 1908

Pregnancy Outcomes in the Tofacitinib RA Safety Database through April 2014
Abstract Number: 793

Preliminary Analysis of Histological Findings in Diagnosis of Giant Cell Arteritis Biopsy Positive Patients
Abstract Number: 2615

Preliminary Assessment of a Multi-Biomarker Disease Activity Test for Axial Spondyloarthritis
Abstract Number: 210

Preliminary Assessment of Predictive Validity of Cartilage Thickness MRI Biomarkers in Knee OA – the Fnih OA Biomarkers Consortium
Abstract Number: 2788

Preliminary Population- Based Incidence and Prevalence Estimates of SLE: The California Lupus Surveillance Project
Abstract Number: 2293

Preliminary Results from the Childhood Arthritis and Rheumatology Research Alliance Systemic JIA Consensus Treatment Plans Pilot Study
Abstract Number: 252

Preliminary Validation of the Michigan Body Map
Abstract Number: 2670

Premature Delivery in Patients with Systemic Lupus Erythematosus
Abstract Number: 939

Prenatal Methyl-Rich Diet Decreases Inflammation in Collagen Induced Arthritis
Abstract Number: 1073

Prescription Medication Trends in Medicaid-Enrolled Pregnant Women with Rheumatoid Arthritis, Psoriasis, and Systemic Lupus Erythematosus
Abstract Number: 1404

Presence and Significance of Anti-CCP Antibody in Patients with Interstitial Lung Disease with and without Clinically Apparent Rheumatoid Arthritis
Abstract Number: 2082

Presence of Acrocyanosis in Patients with Joint Hypermobility
Abstract Number: 2551

Presence of Germinal Centers at Baseline Is Associated with Clinical Response of Glandular Essdai Domain after Abatacept Treatment in Primary Sjogren’s Syndrome
Abstract Number: 1585

Presence of Swollen and Tender Joints in Patients Fulfilling Minimal Disease Activity Criteria
Abstract Number: 1805

Prevalence and Associating Factors with Atypical Femoral Fractures: An Asian Single Center Based Case-Control Study
Abstract Number: 390

Prevalence and Correlates of Patient-Physician Discordance in Early Rheumatoid Arthritis
Abstract Number: 2441

Prevalence and Determinants of Treatment Adherence Among Patients with Rheumatoid Arthritis
Abstract Number: 2720

Prevalence and Features of Metabolic Syndrome in Systemic Sclerosis
Abstract Number: 1388

Prevalence and Predictive Factors of Drug-Free and Sustained Remission in Patients with Early Arthritis
Abstract Number: 2640

Prevalence and Predictors of ECG Cardiovascular Abnormalities in Lupus Patients
Abstract Number: 1650

Prevalence and Prognostic Implications of IgG4 in Membranous Lupus Nephritis
Abstract Number: 1079

Prevalence of Cardiac Arrhythmias in Systemic Lupus Erythematosus
Abstract Number: 1372

Prevalence of Cardiovascular Disease in US Veterans with Rheumatoid Arthritis and Hepatitis C Infection
Abstract Number: 1550

Prevalence of Enthesitis and Dactylitis, Impact on Disease Severity and Evolution over 12 Months in Psa Patients Treated with Anti-TNF in a Real-World Setting
Abstract Number: 165

Prevalence of Gout in the Adult Population of France in 2013
Abstract Number: 2023

Prevalence of Inflammatory Arthritis Conditions in the First Nations Population of Alberta
Abstract Number: 265

Prevalence of Medicinal Marijuana Use Among 1000 Rheumatology Patients Attending a Community-Based Rheumatology Clinic: A Prospective Cross-Sectional Study
Abstract Number: 418

Prevalence of Morning Stiffness in a US Registry Population of Rheumatoid Arthritis Patients
Abstract Number: 1186

Prevalence of MRI Spinal Lesions Typical for Axial Spondyloarthritis in Patients with Inflammatory Back Pain
Abstract Number: 71

Prevalence of Pain Reporting in Different Ethnic Groups in the UK: Results from a Large Biobank
Abstract Number: 2193

Prevalence of Raynaud’s Phenomenon and Nailfold Capillaroscopic Abnormalities in Fabry’s Disease: A Cross-Sectional Study
Abstract Number: 2024

Prevalence of Rheumatoid Arthritis in French West Indies, an African Ancestry Population. the Eppra Study
Abstract Number: 1285

Prevalence of Risk Factors for Gastrointestinal Side Effects of Drugs for the Treatment of Pain in Rheumatic Diseases and the Provision of Gastroprotective Treatment – Results of a Large Non-Intervention Study
Abstract Number: 40

Prevalence of Spondyloarthritis (ASAS Criteria) in First-Degree Relatives of Patients with Ankylosing Spondylitis
Abstract Number: 2602

Prevalence of Subclinical Atherosclerosis in Patients with Spondyloarthritis without Clinically Evident Cardiovascular Disease Using Carotid Intima-Media Thickness
Abstract Number: 691

Prevalence of Subclinical Echocardiographic Abnormalities in Patients with Systemic Lupus Erythematosus (SLE)
Abstract Number: 142

Prevalence of Subclinical Entheseal Involvement in Patients with Paediatric Inflammatory Bowel Disease: An Ultrasonographic Study
Abstract Number: 141

Prevalence of Subclinical Enthesopathy in Asymptomatic First Degree Relatives of Patients with Spondyloarthritis
Abstract Number: 2423

Prevalence of Subclinical Synovitis Detected By Ultrasound in Rheumatoid Arthritis and Psoriatic Arthritis Patients Receiving Anti-TNF-α Therapy with Extended Interval of Administration
Abstract Number: 1418

Prevalence of Vitamin D Deficiency in Rheumatoid Arthritis
Abstract Number: 1706

Prevention of SU5416-Induced Pulmonary Hypertension in a TGFβ Dependent Genetic Mouse Model of Scleroderma Using the Endothelin Receptor Antagonist Macitentan
Abstract Number: 2406

Primary Non-Adherence, Associated Clinical Outcomes and Healthcare Resource Utilization Among Rheumatoid Arthritis Patients Prescribed Injectable Biologics
Abstract Number: 2548

Primary Sjögren’s Syndrome Is Associated with Significant Cognitive Dysfunction
Abstract Number: 968

Priming of WNT Signalling during Fibrosis Is Mediated By TGF-β Induced Axin-2 Downregulation
Abstract Number: 2874

Pro-Inflammatory FcRL4+ Memory B Cells in Joints of RA Patients: Immunoglobulin Gene Characteristics and Antigen Specificity
Abstract Number: 34

Pro-Nerve Growth Factor (ProNGF) Stimulates Bone Growth By Stimulating Osteoblasts and Inhibiting Osteoclast Differentiation, an Explanation for Anti-NGF-Mediated Osteonecrosis; Prongf Is a Novel Therapeutic Target for Treatment of Osteonecrosis and Charcot’s Arthropathy
Abstract Number: 1667

Probability of 3 and 6 Month Complete Response in Lupus Nephritis
Abstract Number: 1807

Problems with Fee for Service Payments for Academic Rheumatology Practices: A Need for Payment Reform:
Abstract Number: 1988

Process Outcomes and Community-Wide Efficacy of the Amigo Inter-Institutional Mentoring Initiative within Pediatric Rheumatology
Abstract Number: 2569

Profiles of Switches in Patient with Ankylosing Spondylitis: Comparing Adalimumab, Etanercept, Infliximab, Golimumab and Certolizumab
Abstract Number: 1975

Profiling 14-3-3η in Human Primary Cell Based BioMAP^® Disease Models Reveals a Unique Pro-Inflammatory Phenotypic Signature Consistent with RA-Inflammation Biology
Abstract Number: 1606

Profiling a Broad Range of Autoantibodies in Healthy and Systemic Lupus Erythematosis Revealed Autoantibody Patterns Associated with Autoantibody Transition and Disease Activity
Abstract Number: 2605

Profiling Ankylosing Spondylitis Patients Likely to Respond to NSAID Treatment
Abstract Number: 830

Profound Hypouricemia Induced in Human Subjects By Novel Bifunctional Inhibitors of Xanthine Oxidase and URAT1
Abstract Number: 812

Prognosis of Clinically Inactive Takayasu’s Arteritis
Abstract Number: 1784

Prognostic Factors for Interstitial Lung Disease with Microscopic Polyangiitis
Abstract Number: 2491

Prognostic Factors for IV Abatacept Retention in Patients Who Have Received at Least One Prior Biologic Agent: 2-Year Results from a Prospective, International, Real-World Study
Abstract Number: 2981

Prognostic Value of the Complex P2X7 Receptor-Inflammasome in Patients with Primary Sjögren’s Syndrome at Lymphoma Risk
Abstract Number: 3017

Program Evaluation of ‘the Joint Clinic’: An Innovative Clinical Service for Patients with Hip or Knee Osteoarthritis
Abstract Number: 2723

Programmed Death 1 Inhibits T-Cell Adhesion By Regulating Rap1
Abstract Number: 749

Progranulin Overproduction Due to Fli1 Deficiency Contributes to the Resistance of Dermal Fibroblasts to Tumor Necrosis Factor a in Systemic Sclerosis
Abstract Number: 2830

Progression to and Type of Orthopaedic Surgery in Juvenile Vs. Adult-Onset Ankylosing Spondylitis
Abstract Number: 1693

Progressive Disease in Systemic Sclerosis after One Year of Follow-up; Results of a Standardized Multidisciplinary Health Care Program
Abstract Number: 837

Progressive Multifocal Leukoencephalopathy Associated with Biologic Therapy in Rheumatic Diseases: Strengthening Association with Rituximab
Abstract Number: 1198

Prolactin Is Locally Produced in the Synovium of Patients with Inflammatory Arthritic Diseases and Promotes Macrophage Activation
Abstract Number: 1947

Prolactin Promotes Survival of Immature B Cells from MRL/Lpr Mice
Abstract Number: 330

Prolactin Reduces Bone Erosion in Adjuvant-Induced Arthritis
Abstract Number: 1738

Prominent Role of CCR6+ T Helper Cells in the Pathogenesis of ACPA+ Patients with Early RA
Abstract Number: 1238

Proportion of Peripheral Plasmacytoid Dendritic Cells and Plasmablasts Reflects Disease Activity in IgG4-related Disease
Abstract Number: 85

Protective Association of HLA-DRB1*13:02 Against MPO-ANCA Positive ANCA-Associated Vasculitis in a Japanese Population
Abstract Number: 2452

Protective Effect of the IL33 rs3939286 Gene Polymorphism in the Development of Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis
Abstract Number: 702

Protein Losing Enteropathy in Systemic Lupus Erythematosus
Abstract Number: 868

Protein Phosphatase 5 (PP5) Regulates Methylation Sensitive Gene Expression in CD4+ T Cells
Abstract Number: 93

Protein Profiling of Secretome Human Cartilage to Identify Potential EARLY Specific Biomarkers in Osteoarthritis
Abstract Number: 2923

Protein Quantification Using Mass Spectrometry Methods to Predict Response to Abatacept and Methotrexate Combination Therapy in Rheumatoid Arthritis
Abstract Number: 1399

Proteinase K-like Serine Protease PCSK9 Influence on the Dyslipidemia and Endothelial Dysfunction Observed in Rheumatoid Arthritis Patients
Abstract Number: 1755

Proteomic Analysis of ANCA Vasculitis Serum Reveals Broad Neutrophil Activation, Angiogenesis, and Selective Inflammatory Pathway Activation
Abstract Number: 1003

Proteomic Analysis of Connexin 43 Reveals Novel Interactors Related to Osteoarthritis
Abstract Number: 2092

Proteomic Phenotyping of Rheumatoid Arthritis Disease Activity
Abstract Number: 1979

Pseudostarvation By AMPK Activator Therapy Is Associated with Reduced Disease Activity and Downregulation of Pro-Inflammatory Responses in Rheumatoid Arthritis (RA)
Abstract Number: 1562

Psoriasis Longitudinal Assessment and Registry: Global Update upon Full Enrollment
Abstract Number: 2970

Psoriatic Arthritis is Associated with Heterotopic Ossification after Total Hip Arthroplasty
Abstract Number: 546

Psoriatic Arthritis Mutilans: Characteristics and Radiographic Progression
Abstract Number: 1411

Psychological Distress over Time in Early Rheumatoid Arthritis: Results from a Longitudinal Study in an Early Arthritis Cohort
Abstract Number: 2032

Psychological Factors Predict Adherence to Methotrexate (MTX) in Rheumatoid Arthritis (RA); Findings from a Systematic Review of Rates, Predictors and Associations with Patient Outcomes
Abstract Number: 1363

Psychosocial Comorbidities Are Independently Associated with Subclinical Atherosclerosis in Rheumatoid Arthritis
Abstract Number: 1403

Psychosocial Impact of Rheumatoid Arthritis Patients on Their Family Members
Abstract Number: 2172

PTPN22 Promotes TLR-Induced Amelioration of Arthritis
Abstract Number: 778

PTPN22 rs2476601 and Susceptibility to Biopsy Proven Giant Cell Arteritis (GCA) in an Australian Sample
Abstract Number: 1888

PU.1, Mitf, and Their Novel Co-Partner, Eomes, Set up a Transcription Factor Network That Is Critical for Osteoclast Differentiation
Abstract Number: 1871

Puberty and Disease Activity in JIA
Abstract Number: 1261

Pulmonary Arterial Hypertension in Patients with Anti-PM-Scl Antibody
Abstract Number: 1296

Pulse- Pediatric Update on Lupus in South Africa: Epidemiology and Management
Abstract Number: 2765

Putative Blood Biomarkers of Reversible Cerebral Vasoconstriction Syndrome
Abstract Number: 1958

Pyrrolopyrimidine Derivatives That Inhibit Binding of BAFF to Its Receptor, BR3, Are Drug Candidates for Primary Sjögren’s Syndrome